VEGETALLUMINA
VEGETALLUMINA ANTID 10% GEL, 120 G TUBE
VEGETALLUMINA ANTID 10% GEL, 120 G TUBE
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
Name
VEGETALLUMINA Painkiller 10% gel
Ibuprofen lysine salt
What is it and what is it for?
VEGETALLUMINA Antidolore contains ibuprofen lysine which is an analgesic that belongs to the class of Non-Steroidal Anti-Inflammatory Drugs for external use.
VEGETALLUMINA Antidolore is indicated in the local treatment of bruises, sprains, myalgia (muscle pain), muscle tears, and stiff neck.
Contact your doctor if you notice no improvement or if you notice worsening of your symptoms.
What you need to know before taking the medicine
Do not use VEGETALLUMINA Pain Reliever:
- if you are allergic to ibuprofen lysine or any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to other analgesics (painkillers), antipyretics (feverkillers), non-steroidal anti-inflammatory drugs (NSAIDs) that have previously caused asthma, rhinitis, urticaria or other allergic reactions in the patient;
- if you are pregnant;
- if she is breastfeeding;
- in the case of children and adolescents under 14 years of age.
Warnings and precautions
Talk to your doctor or pharmacist before using VEGETALLUMINA Antidolore.
Do not apply VEGETALLUMINA Antidolore on open wounds or skin lesions.
The use of VEGETALLUMINA Antidolore, especially if prolonged, can give rise to local sensitization phenomena: at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity, discontinue treatment and consult your doctor who will be able to adopt appropriate therapeutic measures.
To avoid more serious hypersensitivity or photosensitivity (sensitivity to light) phenomena, do not expose yourself to direct sunlight, including solarium, during treatment and for two weeks after.
In case of more serious allergic reactions (skin reactions, some of which are fatal, such as exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis), discontinue therapy immediately and consult your doctor.
Severe skin reactions
Serious skin reactions, including exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment.
Stop using Vegetallumina pain reliever and contact your doctor immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
If the use of acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs has caused asthma, rhinitis, urticaria, or other allergic reactions, consult your doctor before taking the medicine. It is also advisable to consult your doctor if these conditions have occurred in the past.
Consult your doctor if you are taking anticoagulants at the same time (see Other medicines and VEGETALLUMINA Antidolore ).
Children and adolescents
The use of the medicine is reserved only for patients over 14 years of age.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.
Skin reactions with erythema, itching, irritation, sensation of heat or burning and contact dermatitis have been reported with some non-steroidal anti-inflammatory drugs derived from propionic acid for local or transdermal use (through the skin).
Photosensitivity reactions (the skin becomes sensitive to light) are possible.
Stop using ibuprofen and see your doctor immediately if you notice any of the following symptoms:
• flat, target-shaped or circular reddish patches on the trunk, often with central blisters, peeling skin, and ulcers of the mouth, throat, nose, genitals, and eyes. These severe rashes may be preceded by fever and flu-like symptoms [exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis].
• Widespread skin rash, high body temperature and swollen lymph nodes (DRESS syndrome).
• Widespread, red, scaly rash with bumps under the skin and blisters, accompanied by fever. Symptoms usually appear at the start of treatment (acute generalized exanthematous pustulosis).
Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.
VEGETALLUMINA Painkiller 10% gel
Ibuprofen lysine salt
What is it and what is it for?
VEGETALLUMINA Antidolore contains ibuprofen lysine which is an analgesic that belongs to the class of Non-Steroidal Anti-Inflammatory Drugs for external use.
VEGETALLUMINA Antidolore is indicated in the local treatment of bruises, sprains, myalgia (muscle pain), muscle tears, and stiff neck.
Contact your doctor if you notice no improvement or if you notice worsening of your symptoms.
What you need to know before taking the medicine
Do not use VEGETALLUMINA Pain Reliever:
- if you are allergic to ibuprofen lysine or any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to other analgesics (painkillers), antipyretics (feverkillers), non-steroidal anti-inflammatory drugs (NSAIDs) that have previously caused asthma, rhinitis, urticaria or other allergic reactions in the patient;
- if you are pregnant;
- if she is breastfeeding;
- in the case of children and adolescents under 14 years of age.
Warnings and precautions
Talk to your doctor or pharmacist before using VEGETALLUMINA Antidolore.
Do not apply VEGETALLUMINA Antidolore on open wounds or skin lesions.
The use of VEGETALLUMINA Antidolore, especially if prolonged, can give rise to local sensitization phenomena: at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity, discontinue treatment and consult your doctor who will be able to adopt appropriate therapeutic measures.
To avoid more serious hypersensitivity or photosensitivity (sensitivity to light) phenomena, do not expose yourself to direct sunlight, including solarium, during treatment and for two weeks after.
In case of more serious allergic reactions (skin reactions, some of which are fatal, such as exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis), discontinue therapy immediately and consult your doctor.
Severe skin reactions
Serious skin reactions, including exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment.
Stop using Vegetallumina pain reliever and contact your doctor immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
If the use of acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs has caused asthma, rhinitis, urticaria, or other allergic reactions, consult your doctor before taking the medicine. It is also advisable to consult your doctor if these conditions have occurred in the past.
Consult your doctor if you are taking anticoagulants at the same time (see Other medicines and VEGETALLUMINA Antidolore ).
Children and adolescents
The use of the medicine is reserved only for patients over 14 years of age.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.
Skin reactions with erythema, itching, irritation, sensation of heat or burning and contact dermatitis have been reported with some non-steroidal anti-inflammatory drugs derived from propionic acid for local or transdermal use (through the skin).
Photosensitivity reactions (the skin becomes sensitive to light) are possible.
Stop using ibuprofen and see your doctor immediately if you notice any of the following symptoms:
• flat, target-shaped or circular reddish patches on the trunk, often with central blisters, peeling skin, and ulcers of the mouth, throat, nose, genitals, and eyes. These severe rashes may be preceded by fever and flu-like symptoms [exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis].
• Widespread skin rash, high body temperature and swollen lymph nodes (DRESS syndrome).
• Widespread, red, scaly rash with bumps under the skin and blisters, accompanied by fever. Symptoms usually appear at the start of treatment (acute generalized exanthematous pustulosis).
Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.
VEGETALLUMINA
VEGETALLUMINA ANTID 10% GEL, 120 G TUBE
VEGETALLUMINA ANTID 10% GEL, 120 G TUBE
MINSAN code: 041734029
Previous price: €13,62
Regular price
€15,00
Regular price
€0,00
Sale price
€15,00
Unit price
per
Tax included.
Shipping calculated at checkout.
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
